Literature DB >> 10527559

Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus.

C L Bowlus1, J Ahn, T Chu, J R Gruen.   

Abstract

Antigen presentation by cortical thymic epithelial cells (cTEC) during the positive selection of T cells has been shown to differ from that of other antigen-presenting cells. In the case of MHC class II presentation, cathepsin L as opposed to cathepsin S is responsible at least in part for the degradation of invariant chain. Other proteases, however, must be involved. We have identified a putative serine protease that is specifically expressed in the thymus. Encoded within the class I major histocompatibility complex (MHC) region, this gene has sequence homology with lysosomal prolylcarboxypeptidase, suggesting that it is a serine protease. We have, therefore, designated this gene thymus-specific serine protease (TSSP). In situ hybridization and immunofluorescence staining reveal that TSSP is expressed exclusively by cortical thymic epithelial cells, with the strongest staining noted around vessels and the thymic capsule. The identification of TSSP further supports the theory that MHC class II antigen processing and presentation in the thymic cortex involves a proteolytic milieu that differs from that of other antigen-presenting cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527559     DOI: 10.1006/cimm.1999.1543

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  19 in total

Review 1.  Diversity in MHC class II antigen presentation.

Authors:  John H Robinson; Alexei A Delvig
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  Thymic stromal cell subsets for T cell development.

Authors:  Takeshi Nitta; Harumi Suzuki
Journal:  Cell Mol Life Sci       Date:  2016-01-29       Impact factor: 9.261

Review 3.  Antigen presentation in the thymus for positive selection and central tolerance induction.

Authors:  Ludger Klein; Maria Hinterberger; Gerald Wirnsberger; Bruno Kyewski
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

4.  Prss16 is not required for T-cell development.

Authors:  Saijai Cheunsuk; Zhe-Xiong Lian; Guo-Xiang Yang; M Eric Gershwin; Jeffrey R Gruen; Christopher L Bowlus
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice.

Authors:  Christophe Viret; Stéphane Leung-Theung-Long; Laurent Serre; Camille Lamare; Dario A A Vignali; Bernard Malissen; Alice Carrier; Sylvie Guerder
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

6.  Transcription profiling of Prss16 (Tssp) can be used to find additional peptidase genes that are candidates for self-peptide generation in the thymus.

Authors:  Thaís A Fornari; Márcia M Marques; Catherine Nguyen; Alice Carrier; Geraldo A Passos
Journal:  Mol Biol Rep       Date:  2011-07-20       Impact factor: 2.316

7.  Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7).

Authors:  Marie-Berthe Maes; Anne-Marie Lambeir; Kambiz Gilany; Kristel Senten; Pieter Van der Veken; Barbara Leiting; Koen Augustyns; Simon Scharpé; Ingrid De Meester
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

8.  Thymic epithelial requirement for γδ T cell development revealed in the cell ablation transgenic system with TSCOT promoter.

Authors:  Gwanghee Lee; Ki Yeon Kim; Cheong-Hee Chang; Moon Gyo Kim
Journal:  Mol Cells       Date:  2012-11-15       Impact factor: 5.034

Review 9.  Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire.

Authors:  Sylvie Guerder; Chervin Hassel; Alice Carrier
Journal:  Immunogenetics       Date:  2018-09-17       Impact factor: 2.846

Review 10.  Thymoproteasome optimizes positive selection of CD8+ T cells without contribution of negative selection.

Authors:  Izumi Ohigashi; Yousuke Takahama
Journal:  Adv Immunol       Date:  2021-05-01       Impact factor: 3.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.